Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

<i>mMgat2</i> and <i>HuMgat2</i> mice exhibit a transcriptomic profile indicating impairments in metabolite detoxification and lipid metabolic processes. by J. Jose Corbalan (22439198)

Subjects:

Estimated marginal mean (± SE) age group differences in the relative frequency of ball touches per minute, performed by professional soccer players on a match day for each position... by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”

Association between GSRS and CD8⁺ T cell infiltration levels in the TCGA-KIRC cohort, and the infiltration proportion of CD8⁺ T cells was evaluated using mult... by Yu Zhang (12946)

Subjects:

A) CaCO₃ content versus number of treatments; B) UCS versus calcium carbonate content; C) permeability coefficient versus calcium carbonate content. by Jin Zhu (164147)

Subjects: “…permeability coefficients decreased…”

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited larvicidal activity against larvae of <i>A</i>. <i>albopictu</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>A</i>. <i>salina</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

SEM images of alkali-activated samples JW1 at a magnification of ×5000. by Liang Li (46069)

Subjects:

SEM images of alkali-activated samples JW3 at a magnification of ×5000. by Liang Li (46069)

Subjects:

SEM images of alkali-activated samples JW1 at a magnification of ×5000. by Liang Li (46069)

Subjects:

SEM images of alkali-activated samples JW3 at a magnification of ×5000. by Liang Li (46069)

Subjects:

A conceptual framework illustrating the role of community safe spaces in overcoming structural violence. by Patrick Mbullo Owuor (20776036)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects: